Last week saw a number of broker notes hitting the wires once again. Three buy ratings that investors might want to be aware of are summarised below.
Here's why brokers think investors ought to buy them next week:
Image source: Getty Images
Argosy Minerals Limited (ASX: AGY)
According to a note out of Macquarie, its analysts have retained their outperform rating and 80 cents price target on this lithium developer's shares. This follows news that its Rincon lithium project in Argentina is almost fully commissioned. This leaves the company well-placed to be generating material free cash flow in the near future. Especially given how its ramp up to 2,000 tonnes per annum production is expected to take less than six months. The Argosy Minerals share price ended the week at 40 cents.
CSL Limited (ASX: CSL)
A note out of Morgan Stanley reveals that its analysts have retained their overweight rating and $339.00 price target on this biotherapeutics giant's shares. Morgan Stanley was pleased with what it saw at the company's European Investor Site Tour. The broker came away from the event feeling even more confident about CSL's margin outlook. The CSL share price was fetching $300.18 at Thursday's close.
Lynas Rare Earths Ltd (ASX: LYC)
Analysts at Bell Potter have upgraded this rare earths producer's shares to a buy rating with a slightly trimmed price target of $8.06. While Bell Potter acknowledges that there are some near term earnings risks to consider, it feels the recent Tesla-induced selloff has been an overreaction. Bell Potter sees multiple long-term growth pathways outside Tesla, which will be underpinned by arguably the best rare-earth deposit at Mt Weld. The Lynas share price was trading at $6.06 at the end of the week.
